Table 2.
Study | Kidney function | Imaging modality | Site imaged | Fracture site | Area under the receiver operator curve | Sensitivity | Specificity |
---|---|---|---|---|---|---|---|
Jamal et al. (2006)66 | ESRD | DXA pQCT | Total hip | Any site | 56 | 26 | 78 |
Radius (cortical density) | Any site | 89 | NA | NA | |||
Radius (trabecular density) | Any site | 52 | NA | NA | |||
Jamal et al. (2002)65 | ESRD | DXA | Femoral neck | Any site | 47.3 | 26 | 78 |
Ultrasound | Calcaneous | Any site | 56.2 | 29 | 78 | ||
Fontaine et al. (2000)85 | ESRD | DXA | Femoral neck | Any site | 75.5 | NA | NA |
Radius (mid) | Any site | 83.7 | NA | NA | |||
Radius (one-third) | Any site | 78.0 | NA | NA | |||
Lumbar Spine | Any site | 72.8 | NA | NA | |||
Yamaguchi et al. (1996)52 | ESRD | DXA | Lumbar spine | Vertebral | 72.9 | 70 | 70 |
Non-spine | 69.3 | 63 | 63 | ||||
Radius (one-third) | Vertebral | 75.2 | 69 | 69 | |||
Radius (ultradistal) | Non-spine | 86.9 | 82 | 82 | |||
Atsumi et al. (1999)21 | ESRD | DXA | Total body | Vertebral | 55 | NA | NA |
Lumbar spine | Vertebral | 60 | NA | NA |
CKD, chronic kidney disease; DXA, dual-energy X-ray absorptiometry; ESRD, end-stage renal disease; NA, not applicable; pQCT, peripheral quantitative computed tomography.